Ripretinib

Ripretinib

CAT N°: 33782
Price:

From 122.00 103.70

Ripretinib is an inhibitor of KIT and PDGFR? (IC50s = 3 and 3.6 nM, respectively).{53053} It is selective for KIT and PDGFR? over a panel of 300 kinases (IC50s = >100 nM) but does inhibit DDR2, VEGFR2, PDGFR?, and Tie2 (IC50s = V654A, KITT670I, KITD816H, KITD816V, and PDGFR?D842V (IC50s = 11, 9.2, 18, 25, and 36 nM, respectively). Ripretinib induces apoptosis in ROSA wild-type, and KITD816V- or KITK509I-expressing mast cells in a concentration-dependent manner.{53054} It reduces tumor growth and increases survival in an imatinib-resistant patient-derived xenograft (PDX) mouse model of gastrointestinal stromal tumors (GISTs) when administered at doses of 50 and 100 mg/kg.{53053} Formulations containing ripretinib have been used in the treatment of GISTs.

We also advise you